Works matching IS 11738804 AND DT 2024 AND VI 38 AND IP 3

Results: 10

Can Endangered Biosimilar Markets be Rescued? The Need to Bridge Competing Interests for Long-Term Gain.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 325, doi. 10.1007/s40259-024-00652-7

By:

Barcina Lacosta, Teresa;
Vulto, Arnold G.;
Turk, Florian;
Huys, Isabelle;
Simoens, Steven

Publication type:

Article

CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 387, doi. 10.1007/s40259-024-00656-3

By:

Rafiq, Muhammad Shahzad;
Shabbir, Muhammad AbuBakar;
Raza, Ahmed;
Irshad, Shoaib;
Asghar, Andleeb;
Maan, Muhammad Kashif;
Gondal, Mushtaq Ahmed;
Hao, Haihong

Publication type:

Article

Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 331, doi. 10.1007/s40259-024-00655-4

By:

Cohen, Hillel P.;
Bodenmueller, Wolfram

Publication type:

Article

Targeted Gene Insertion: The Cutting Edge of CRISPR Drug Development with Hemophilia as a Highlight.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 369, doi. 10.1007/s40259-024-00654-5

By:

Zhang, Zhenjie;
Zhang, Siqi;
Wong, Hoi Ting;
Li, Dali;
Feng, Bo

Publication type:

Article

Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 425, doi. 10.1007/s40259-024-00653-6

By:

Cutroneo, Paola Maria;
Arzenton, Elena;
Furci, Fabiana;
Scapini, Fabio;
Bulzomì, Maria;
Luxi, Nicoletta;
Caminati, Marco;
Senna, Gianenrico;
Moretti, Ugo;
Trifirò, Gianluca

Publication type:

Article

Impact of Early Access Reform on Oncology Innovation in France: Approvals, Patients, and Costs.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 465, doi. 10.1007/s40259-024-00658-1

By:

Martin, Tess;
Rioufol, Catherine;
Favier, Bertrand;
Martelli, Nicolas;
Madelaine, Isabelle;
Chouaid, Christos;
Borget, Isabelle

Publication type:

Article

Research Advances in Stem Cell Therapy for Erectile Dysfunction.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 353, doi. 10.1007/s40259-024-00650-9

By:

Wang, Wei;
Liu, Ying;
Zhu, Zuo-bin;
Pang, Kun;
Wang, Jing-kai;
Gu, Jun;
Li, Zhen-bei;
Wang, Jian;
Shi, Zhen-duo;
Han, Cong-hui

Publication type:

Article

Next-Generation Anti-TNFα Agents: The Example of Ozoralizumab.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 341, doi. 10.1007/s40259-024-00648-3

By:

Tsumoto, Kouhei;
Takeuchi, Tsutomu

Publication type:

Article

Use of Biosimilars: A Systematic Review of Published Position Statements and Recommendations from Health Organisations and Societies.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 405, doi. 10.1007/s40259-024-00649-2

By:

Mohd Sani, Noraisyah;
Aziz, Zoriah;
Kamarulzaman, Adeeba

Publication type:

Article

Consensus-Based Overarching Principles and Recommendations on the Use of Biosimilars in the Treatment of Inflammatory Arthritis in the Gulf Region.

Published in:

BioDrugs, 2024, v. 38, n. 3, p. 449, doi. 10.1007/s40259-023-00642-1

By:

Alnaqbi, Khalid A.;
Al Adhoubi, Nasra;
Aldallal, Sara;
Al Emadi, Samar;
Al-Herz, Adeeba;
El Shamy, Amin M.;
Hannawi, Suad;
Omair, Mohammed A.;
Saad, Sahar A.;
Kvien, Tore K.

Publication type:

Article